CRISPR Therapeutics AG

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
CRISPR Therapeutics AG
TickerCRSP
CIK #0001674416
CUSIPH17182108
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
AddressAeschenvorstadt 36, Basel, 4051
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
CRISPR Therapeutics AG 2020-04-09 1.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001674416] 10-K
[0001674416] 10-Q
[0001674416] 3
[0001674416] 4
[0001674416] 8-K
[0001674416] D
[0001674416] SC 13D
[0001674416] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Capital World Investors CRISPR Therapeutics AG [2026-05-14] 0.0
Orbis Investment Management Ltd CRISPR Therapeutics AG [2025-11-14] 0.0
BlackRock Inc CRISPR Therapeutics AG [2025-07-17] 0.0
Capital International Investors CRISPR Therapeutics AG [2023-02-13] 7.1
Ark Investment Management LLC CRISPR Therapeutics AG [2020-10-09] 12.05
Capital International Investors CRISPR Therapeutics AG [2020-09-10] 10.7
Capital International Investors CRISPR Therapeutics AG [2020-09-10] 10.7
Sumitomo Mitsui Trust Holdings Inc CRISPR Therapeutics AG [2020-02-12] 5.08
Nikko Asset Management Americas Inc CRISPR Therapeutics AG [2020-02-12] 5.08
Vertex Pharmaceuticals Inc / Ma CRISPR Therapeutics AG [2019-11-26] 0.1
Vertex Pharmaceuticals Inc / Ma CRISPR Therapeutics AG [2018-12-21] 10.1
Vertex Pharmaceuticals Inc / Ma CRISPR Therapeutics AG [2017-02-13] 8.0
New Enterprise Associates 15 LP CRISPR Therapeutics AG [2017-02-06] 8.1
Versant Venture Capital IV LP CRISPR Therapeutics AG [2016-11-03] 11.0
Abingworth LLP CRISPR Therapeutics AG [2016-11-03] 6.6
Celgene Corp /DE/ CRISPR Therapeutics AG [2016-10-31] 12.3
GlaxoSmithKline PLC CRISPR Therapeutics AG [2016-10-28] 8.3
Bayer Global Investments BV CRISPR Therapeutics AG [2016-10-28] 12.8
Form 3/4/5 Filer 2011 - 2026
Treco Douglas A
CRISPR Therapeutics AG
George Simeon
Behbahani Ali
Fardis Maria
Fleming Harold Edward
Greene John
High Katherine A
Mahatme Sandesh
Morrison Briggs
Rommel Christian
Prasad Raju
Kasinger James R
Patel Naimish
Kulkarni Samarth
Bruno Julianne
Morrow Phuong Khanh
Smith Brendan
Klein Lawrence Otto
Bolzon Bradley J PhD
Ho Tony W
Tomsicek Michael John
Novak Rodger
Cagnoni Pablo J
Vertex Pharmaceuticals Europe Ltd
Vertex Pharmaceuticals Inc / Ma
Emster Kurt von
Woiwode Thomas
Versant Ventures V LLC
Versant Venture Capital V LP
Versant Affiliates Fund V LP
Versant Venture Capital V Canada LP
Versant Ophthalmic Affiliates I LP
Versant Venture Capital IV LP
Versant Side Fund IV LP
Versant Ventures IV LLC
Bayer Aktiengesellschaft
Bayer Global Investments BV
Dylan-Hyde Tyler
Celgene Corp /DE/
Versant Ventures V Canada LP
Subramanian Kala
Coles N Anthony
Lundberg Sven Ante
GlaxoSmithKline PLC
Hadley Harbor Master Investors Cayman LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Prasad Raju
Common Shares
2026-03-23 Sell 3,708 $46.78 173,460
Kulkarni Samarth
Common Shares
2026-03-23 Sell 10,020 $46.78 468,736
Kasinger James R
Common Shares
2026-03-23 Sell 3,182 $46.78 148,854
Prasad Raju
Restricted Stock Units · derivative
2026-03-20 Option exercise 6,250
Kulkarni Samarth
Restricted Stock Units · derivative
2026-03-20 Option exercise 19,687
Kasinger James R
Restricted Stock Units · derivative
2026-03-20 Option exercise 6,250
Kasinger James R
Common Shares
2026-03-20 Option exercise 6,250
Kulkarni Samarth
Stock Option (Right to Buy) · derivative
2026-03-20 Grant 114,249 $0.00
Prasad Raju
Common Shares
2026-03-20 Option exercise 6,250
Patel Naimish
Stock Option (Right to Buy) · derivative
2026-03-20 Grant 38,499 $0.00
Kulkarni Samarth
Restricted Stock Units · derivative
2026-03-20 Grant 81,875 $0.00
Kulkarni Samarth
Common Shares
2026-03-20 Option exercise 19,687
Kasinger James R
Stock Option (Right to Buy) · derivative
2026-03-20 Grant 38,499 $0.00
Patel Naimish
Restricted Stock Units · derivative
2026-03-20 Grant 30,000 $0.00
Prasad Raju
Restricted Stock Units · derivative
2026-03-20 Grant 27,500 $0.00
Kasinger James R
Restricted Stock Units · derivative
2026-03-20 Grant 25,000 $0.00
Prasad Raju
Stock Option (Right to Buy) · derivative
2026-03-20 Grant 38,499 $0.00
Kulkarni Samarth
Common Shares
2026-03-16 Sell 10,349 $48.26 499,443
Prasad Raju
Common Shares
2026-03-16 Gift 750 $0.00
Patel Naimish
Common Shares
2026-03-16 Sell 3,150 $48.26 152,019
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 496 77,518,406
2025-12-31 493 78,961,649
2025-09-30 456 76,131,811
2025-06-30 445 75,337,992
2025-03-31 402 63,703,900
2024-12-31 409 62,984,391
2024-09-30 421 59,187,232
2024-06-30 457 58,847,271
2024-03-31 491 62,345,636
2023-12-31 484 57,518,412
2023-09-30 416 51,798,186
2023-06-30 429 52,181,652
Form 13F Holdings
Firm Period DFND Voting Shares
Congress Asset Management Co [2026-06-30] SOLE 97,253 109,453
Wealth Enhancement Trust Services Inc [2026-06-30] SOLE 0 38,753
Bouvel Investment Partners LLC [2026-06-30] SOLE 32,466 32,466
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 30,485 30,485
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 1,141 25,163
Ipswich Investment Management Co Inc [2026-06-30] SOLE 23,798 23,798
Patriot Financial Group Insurance Agency LLC [2026-06-30] SOLE 23,648 23,648
Brave Asset Management Inc [2026-06-30] SOLE 11,234 11,234
Merit Financial Group LLC [2026-06-30] SOLE 0 9,925
Farther Finance Advisors LLC [2026-06-30] SOLE 0 7,956
180 Wealth Advisors LLC [2026-06-30] SOLE 4,753 7,257
Steel Peak Wealth Management LLC [2026-06-30] SOLE 3,883 6,314
Independent Financial Group LLC [2026-06-30] SOLE 0 6,062
IVC Wealth Advisors LLC [2026-06-30] SOLE 0 5,305
PSP Research LLC [2026-06-30] SOLE 0 5,000
Interchange Capital Partners LLC [2026-06-30] SOLE 0 4,498
Quad-Cities Investment Group LLC [2026-06-30] SOLE 0 4,164
Prospera Financial Services Inc [2026-06-30] SOLE 0 3,928
Valeo Financial Advisors LLC [2026-06-30] SOLE 3,689 3,689
Spire Wealth Management [2026-06-30] SOLE 0 2,718
HM Payson & Co [2026-06-30] SOLE 2,320 2,320
Harbor Investment Advisory LLC [2026-06-30] SOLE 2,300 2,300
Thurston Springer Miller Herd & Titak Inc [2026-06-30] SOLE 1,637 1,637
IFP Advisors LLC [2026-06-30] SOLE 1,242 1,242
Highline Wealth Partners LLC [2026-06-30] SOLE 1,000 1,000
Curated Wealth Partners LLC [2026-06-30] OTR 0 713
Merit Financial Group LLC [2026-06-30] OTR 0 688
Gamma Investing LLC [2026-06-30] DFND 649 649
Salem Investment Counselors Inc [2026-06-30] SOLE 0 535
Country Trust Bank [2026-06-30] SOLE 500 500
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com